Literature DB >> 18394993

Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.

Meelad M Dawlaty1, Liviu Malureanu, Karthik B Jeganathan, Esther Kao, Claudio Sustmann, Samuel Tahk, Ke Shuai, Rudolf Grosschedl, Jan M van Deursen.   

Abstract

RanBP2 is a nucleoporin with SUMO E3 ligase activity that functions in both nucleocytoplasmic transport and mitosis. However, the biological relevance of RanBP2 and the in vivo targets of its E3 ligase activity are unknown. Here we show that animals with low amounts of RanBP2 develop severe aneuploidy in the absence of overt transport defects. The main chromosome segregation defect in cells from these mice is anaphase-bridge formation. Topoisomerase IIalpha (Topo IIalpha), which decatenates sister centromeres prior to anaphase onset to prevent bridges, fails to accumulate at inner centromeres when RanBP2 levels are low. We find that RanBP2 sumoylates Topo IIalpha in mitosis and that this modification is required for its proper localization to inner centromeres. Furthermore, mice with low amounts of RanBP2 are highly sensitive to tumor formation. Together, these data identify RanBP2 as a chromosomal instability gene that regulates Topo IIalpha by sumoylation and suppresses tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18394993      PMCID: PMC2693193          DOI: 10.1016/j.cell.2008.01.045

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  33 in total

1.  Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex.

Authors:  Hong Zhang; Hisato Saitoh; Michael J Matunis
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

2.  Beginning at the end with SUMO.

Authors:  Michael J Matunis; Cecile M Pickart
Journal:  Nat Struct Mol Biol       Date:  2005-07       Impact factor: 15.369

3.  PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes.

Authors:  Yoshiaki Azuma; Alexei Arnaoutov; Tadashi Anan; Mary Dasso
Journal:  EMBO J       Date:  2005-06-02       Impact factor: 11.598

Review 4.  Can chromosomal instability initiate tumorigenesis?

Authors:  Franziska Michor; Yoh Iwasa; Bert Vogelstein; Christoph Lengauer; Martin A Nowak
Journal:  Semin Cancer Biol       Date:  2005-02       Impact factor: 15.707

5.  Crm1 is a mitotic effector of Ran-GTP in somatic cells.

Authors:  Alexei Arnaoutov; Yoshiaki Azuma; Katharina Ribbeck; Jomon Joseph; Yekaterina Boyarchuk; Tatiana Karpova; James McNally; Mary Dasso
Journal:  Nat Cell Biol       Date:  2005-06       Impact factor: 28.824

6.  The Rae1-Nup98 complex prevents aneuploidy by inhibiting securin degradation.

Authors:  Karthik B Jeganathan; Liviu Malureanu; Jan M van Deursen
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

Review 7.  Segregating sister genomes: the molecular biology of chromosome separation.

Authors:  Kim Nasmyth
Journal:  Science       Date:  2002-07-26       Impact factor: 47.728

8.  Gene-expression profiles predict survival of patients with lung adenocarcinoma.

Authors:  David G Beer; Sharon L R Kardia; Chiang-Ching Huang; Thomas J Giordano; Albert M Levin; David E Misek; Lin Lin; Guoan Chen; Tarek G Gharib; Dafydd G Thomas; Michelle L Lizyness; Rork Kuick; Satoru Hayasaka; Jeremy M G Taylor; Mark D Iannettoni; Mark B Orringer; Samir Hanash
Journal:  Nat Med       Date:  2002-07-15       Impact factor: 53.440

9.  SUMO-1 targets RanGAP1 to kinetochores and mitotic spindles.

Authors:  Jomon Joseph; Shyh-Han Tan; Tatiana S Karpova; James G McNally; Mary Dasso
Journal:  J Cell Biol       Date:  2002-02-18       Impact factor: 10.539

10.  Nup358 integrates nuclear envelope breakdown with kinetochore assembly.

Authors:  Davide Salina; Paul Enarson; J B Rattner; Brian Burke
Journal:  J Cell Biol       Date:  2003-09-08       Impact factor: 10.539

View more
  153 in total

1.  BubR1 is modified by sumoylation during mitotic progression.

Authors:  Feikun Yang; Liyan Hu; Cheng Chen; Jianxiu Yu; Christopher B O'Connell; Alexey Khodjakov; Michele Pagano; Wei Dai
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

2.  Sumoylated BubR1 plays an important role in chromosome segregation and mitotic timing.

Authors:  Feikun Yang; Ying Huang; Wei Dai
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

3.  Coordinating postmitotic nuclear pore complex assembly with abscission timing.

Authors:  Douglas R Mackay; Katharine S Ullman
Journal:  Nucleus       Date:  2011-07-01       Impact factor: 4.197

4.  Rod/Zw10 complex is required for PIASy-dependent centromeric SUMOylation.

Authors:  Hyunju Ryu; Yoshiaki Azuma
Journal:  J Biol Chem       Date:  2010-08-09       Impact factor: 5.157

Review 5.  Nuclear transport and the mitotic apparatus: an evolving relationship.

Authors:  Richard Wozniak; Brian Burke; Valérie Doye
Journal:  Cell Mol Life Sci       Date:  2010-04-08       Impact factor: 9.261

Review 6.  Orchestrating nuclear envelope disassembly and reassembly during mitosis.

Authors:  Stephan Güttinger; Eva Laurell; Ulrike Kutay
Journal:  Nat Rev Mol Cell Biol       Date:  2009-03       Impact factor: 94.444

Review 7.  SUMO modification of DNA topoisomerase II: trying to get a CENse of it all.

Authors:  Ming-Ta Lee; Jeff Bachant
Journal:  DNA Repair (Amst)       Date:  2009-02-20

8.  Cyclin B2 and p53 control proper timing of centrosome separation.

Authors:  Hyun-Ja Nam; Jan M van Deursen
Journal:  Nat Cell Biol       Date:  2014-04-28       Impact factor: 28.824

Review 9.  SUMO: a multifaceted modifier of chromatin structure and function.

Authors:  Caelin Cubeñas-Potts; Michael J Matunis
Journal:  Dev Cell       Date:  2013-01-14       Impact factor: 12.270

10.  Differential effects of human immunodeficiency virus type 1 capsid and cellular factors nucleoporin 153 and LEDGF/p75 on the efficiency and specificity of viral DNA integration.

Authors:  Yasuhiro Koh; Xiaolin Wu; Andrea L Ferris; Kenneth A Matreyek; Steven J Smith; KyeongEun Lee; Vineet N KewalRamani; Stephen H Hughes; Alan Engelman
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.